Is GW Pharmaceuticals Finally Getting Some Competition?

GW Pharmaceuticals (NASDAQ:GWPH) boasts the first plant-based cannabinoid pharmaceutical agent on the market with its treatment, Epidiolex. The Food and Drug Administration approved Epidiolex in June 2018 as a treatment for seizures

Read more »

3 Marijuana Stocks to Avoid at All Costs

Last year, investors were left waiting for marijuana stocks to make their big comeback.  This year, though, it looks like a rally is starting to materialize. That makes now a great

Read more »

Why are Shares of GW Pharmaceuticals Trading Down 10% Today?

You might think that skyrocketing sales would translate to tremendous share price appreciation. But that wasn’t the case for GW Pharmaceuticals (NASDAQ:GWPH) in 2019. The stock finished the year up only 7%

Read more »

Aurora Cannabis Gets a Downgrade and Price Target Increase in the Same Day

This week got off to a rocky start for the stock markets as indexes plunged yesterday.  To make matters worse for cannabis stocks, Cowen downgraded Aurora Cannabis (ACB), Tilray (TLRY)

Read more »

5 Best Cannabis Stocks to Own for the Next Decade

Cannabis stocks haven’t exactly shone over the last year. Capital constraints, weak internal controls, overaggressive management teams, regulatory bottlenecks, exceedingly high tax rates, a thriving black market, and unrealistic expectations

Read more »

3 Reasons Why You Should Avoid Tilray (TLRY)

It’s been a volatile couple of years for shares of Tilray (TLRY).  The stock reached $300 in 2018 and last month, it hit $15, a new all-time low.  And though

Read more »

The 4 Biggest Cannabis Stock Catalysts in 2020

Putting aside the fact that 2019 was not a good year for cannabis stocks, we’ve witnessed a lot of history being made in recent years. In 2018, Canada became the first

Read more »

Why Innovative Industrial Properties (IIPR) is Still One of Our Favorite Pot Stocks

Just 4 months ago, we published an article on www.StockNews.com titled, “Is Now a Great Time to Buy Innovative Industrial Properties Inc.,” in which we shared our opinion that the

Read more »

Is Canopy Growth the Best Pot Stock to Buy Right Now?

Canopy Growth Corporation (NYSE:CGC) reported better-than-expected fiscal 2020 third-quarter results last Friday. In turn, the market bid the pot titan’s stock up by a healthy 13.4% on extremely heavy volume. Heading into Canopy’s latest

Read more »

The Most Important Number to Look at Before Buying a Pot Stock

When a company releases its earnings report, two main items are typically the focus for analysts and investors — revenue and earnings. While those are important numbers to keep an

Read more »